Literature DB >> 17240300

Intestinal type adenocarcinoma: a previously unrecognized histologic variant of ductal carcinoma of the pancreas.

Jorge Albores-Saavedra1, Karen Simpson, Yeong-Ju Dancer, Ralph Hruban.   

Abstract

Adenocarcinomas with intestinal differentiation have been described in a wide variety of anatomical sites. To our knowledge, however, ductal adenocarcinomas with intestinal phenotype have not been described in the pancreas. We report here 11 ductal carcinomas of the pancreas that were morphologically similar to colonic adenocarcinomas. These pancreatic carcinomas of intestinal type represented 10% of 110 consecutively removed ductal carcinomas of the pancreas. All intestinal type carcinomas expressed cytokeratin 7, carcinoembryonic antigen, CDX2, and MUC2. The pattern of reactivity of cytokeratin 7 and carcinoembryonic antigen was diffuse, whereas that of mucin 2 staining and CDX2 nuclear labeling was focal and confined predominantly to goblet cells and less frequently to columnar cells. Six carcinomas contained collections of endocrine cells admixed with the columnar and goblet cells. Five carcinomas were associated with high-grade pancreatic intraepithelial neoplasia of intestinal type. Six patients were female and 5 were male. Their ages ranged from 52 to 76 years (mean age, 61 years). The clinical presentation did not differ from that of the conventional ductal carcinomas. All carcinomas originated in the head of the pancreas, and 5 had metastasized to the regional lymph nodes at the time of surgical resection. Only 1 patient survived 5 years. Three patients are disease free from 2.8 to 8.9 months after surgery. Six patients died as a direct result of the carcinomas, and 1 was lost to follow-up. More studies are needed to determine the biologic behavior of this distinctive histologic variant of ductal adenocarcinoma of the pancreas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17240300     DOI: 10.1016/j.anndiagpath.2006.06.008

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  7 in total

1.  Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas.

Authors:  V Sandhu; I M Bowitz Lothe; K J Labori; O C Lingjærde; T Buanes; A M Dalsgaard; M L Skrede; J Hamfjord; T Haaland; T J Eide; A-L Børresen-Dale; T Ikdahl; E H Kure
Journal:  Mol Oncol       Date:  2014-12-19       Impact factor: 6.603

2.  Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin.

Authors:  Peter Bronsert; Ilona Kohler; Martin Werner; Frank Makowiec; Simon Kuesters; Jens Hoeppner; Ulrich Theodor Hopt; Tobias Keck; Dirk Bausch; Ulrich Friedrich Wellner
Journal:  BMC Cancer       Date:  2013-09-22       Impact factor: 4.430

3.  Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines.

Authors:  Anna B Wennerström; Inger Marie Bowitz Lothe; Vandana Sandhu; Elin H Kure; Ola Myklebost; Else Munthe
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

4.  Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours.

Authors:  Arne Westgaard; Aasa R Schjølberg; Milada Cvancarova; Tor J Eide; Ole Petter F Clausen; Ivar P Gladhaug
Journal:  Histopathology       Date:  2009-02       Impact factor: 5.087

5.  Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.

Authors:  Arne Westgaard; Svetlana Tafjord; Inger N Farstad; Milada Cvancarova; Tor J Eide; Oystein Mathisen; Ole Petter F Clausen; Ivar P Gladhaug
Journal:  BMC Cancer       Date:  2008-06-11       Impact factor: 4.430

6.  Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic Stratification.

Authors:  Carlos Fernández Moro; Alejandro Fernandez-Woodbridge; Melroy Alistair D'souza; Qianni Zhang; Benedek Bozoky; Senthil Vasan Kandaswamy; Piera Catalano; Rainer Heuchel; Sonia Shtembari; Marco Del Chiaro; Olof Danielsson; Mikael Björnstedt; J Matthias Löhr; Bengt Isaksson; Caroline Verbeke; Béla Bozóky
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

7.  Multi-omics analysis of intra-tumoural and inter-tumoural heterogeneity in pancreatic ductal adenocarcinoma.

Authors:  Xiaoqian Liu; Wenqian Wang; Xiaoding Liu; Zhiwen Zhang; Lianyuan Yu; Ruiyu Li; Dan Guo; Weijing Cai; Xueping Quan; Huanwen Wu; Menghua Dai; Zhiyong Liang
Journal:  Clin Transl Med       Date:  2022-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.